Mirum Pharmaceuticals, Inc.
MIRM
Rank in Stocks
#3354
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Share Price
$80.17
Last synced: 2026-10-16
Market Cap
$5.21B
Change (1 day)
-2.69%
Change (1 year)
9.03%
Country
US
Trade Mirum Pharmaceuticals, Inc. (MIRM)
Category
Healthcare
Operating Margin for Mirum Pharmaceuticals, Inc. (MIRM)
Operating Margin as of October 2026 TTM: -17.42%
According to Mirum Pharmaceuticals, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -17.42%. At the end of 2023 the company had an Operating Margin of -58.57%.
Operating Margin history for Mirum Pharmaceuticals, Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -17.42% | -33.00% |
| 2024 | -26.00% | -55.61% |
| 2023 | -58.57% | -65.60% |
| 2022 | -170.28% | -81.21% |
| 2021 | -906.12% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -102.22% |
US
|
|
| -149.01% | -91.45% |
US
|
|
| 25.57% | -101.47% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.65% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.